Published in J Clin Pharmacol on May 01, 1988
Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55(Gag). Proc Natl Acad Sci U S A (2001) 5.83
Crystal structure of a TFIIB-TBP-TATA-element ternary complex. Nature (1995) 4.93
Assembly of recombinant human immunodeficiency virus type 1 capsid protein in vitro. J Virol (1992) 3.44
Processing of in vitro-synthesized gag precursor proteins of human immunodeficiency virus (HIV) type 1 by HIV proteinase generated in Escherichia coli. J Virol (1988) 2.09
Formation of assimilatory nitrate reductase by in vitro inter-cistronic complementation in Neurospora crassa. Proc Natl Acad Sci U S A (1970) 1.84
Activity of purified biosynthetic proteinase of human immunodeficiency virus on natural substrates and synthetic peptides. Proc Natl Acad Sci U S A (1989) 1.81
Identification and cloning of three novel human G protein-coupled receptor genes GPR52, PsiGPR53 and GPR55: GPR55 is extensively expressed in human brain. Brain Res Mol Brain Res (1999) 1.68
Cigarette smoke inhalation decreases alpha 1-antitrypsin activity in rat lung. Science (1979) 1.68
Fauna and geographical distribution of house dust mites in Korea. Korean J Parasitol (1997) 1.57
Tsg101 control of human immunodeficiency virus type 1 Gag trafficking and release. J Virol (2003) 1.56
Agents affecting lipid metabolism. 28. A 7-dehydrocholesterol delta-7-reductase inhibitor (AY-9944) as tool in studies of delta-7-sterol metabolism. Biochemistry (1966) 1.56
A semi-automated determination of phospholipids. Clin Chim Acta (1966) 1.52
Contraindicated medications dispensed with cisapride: temporal trends in relation to the sending of 'Dear Doctor' letters. Pharmacoepidemiol Drug Saf (2001) 1.52
Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trial. J Am Acad Dermatol (1998) 1.49
Endoscopic management of colocutaneous fistula after percutaneous endoscopic gastrostomy. Endoscopy (2002) 1.49
Incidence and prevalence of ulcerative colitis in the Songpa-Kangdong District, Seoul, Korea, 1986-1997. J Gastroenterol Hepatol (2000) 1.43
Discovery of a novel member of the histamine receptor family. Mol Pharmacol (2001) 1.41
Expression in Escherichia coli and purification of human immunodeficiency virus type 1 capsid protein (p24). AIDS Res Hum Retroviruses (1990) 1.40
Potential dangers related to transdermal fentanyl (Duragesic) when used for postoperative pain. Dis Colon Rectum (1994) 1.40
The development of clinical practice guidelines for treatment of peptic acid diseases in a VA ambulatory care clinic. Pharmacotherapy (1996) 1.37
Rat tracheal epithelial cells produce granulocyte/macrophage colony-stimulating factor. Am J Respir Cell Mol Biol (1990) 1.32
HIV-1 capsid protein forms spherical (immature-like) and tubular (mature-like) particles in vitro: structure switching by pH-induced conformational changes. Biophys J (2001) 1.32
Potential RNA polymerase II-induced interactions of transcription factor TFIIB. Mol Cell Biol (1993) 1.27
The role of endoscopic retrograde pancreatography in the treatment of traumatic pancreatic duct injury. Gastrointest Endosc (2001) 1.26
CCAAT binding NF-Y-TBP interactions: NF-YB and NF-YC require short domains adjacent to their histone fold motifs for association with TBP basic residues. Nucleic Acids Res (1997) 1.24
Liquid and solid potassium chloride: bioavailability and safety. Pharmacotherapy (1985) 1.21
The autoimmunity-inducing xenobiotic mercury interacts with the autoantigen fibrillarin and modifies its molecular and antigenic properties. J Immunol (1997) 1.21
Membrane-induced alterations in HIV-1 Gag and matrix protein-protein interactions. J Mol Biol (1998) 1.17
Release of N2,3-ethanoguanine from haloethylnitrosourea-treated DNA by Escherichia coli 3-methyladenine DNA glycosylase II. Carcinogenesis (1991) 1.14
Preparation and crystallization of a human immunodeficiency virus p24-Fab complex. Proc Natl Acad Sci U S A (1990) 1.13
Solid-state (13)C NMR chemical shift anisotropy tensors of polypeptides. J Am Chem Soc (2001) 1.11
A phase I/II study of sepantronium bromide (YM155, survivin suppressor) with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer. Ann Oncol (2013) 1.11
The major homology region of the HIV-1 gag precursor influences membrane affinity. Biochemistry (1996) 1.07
Mechanisms of atomic layer deposition on substrates with ultrahigh aspect ratios. Langmuir (2008) 1.05
Direct interaction of all-trans-retinoic acid with protein kinase C (PKC). Implications for PKC signaling and cancer therapy. J Biol Chem (2000) 1.05
2-Substituted tryptamines: agents with selectivity for 5-HT(6) serotonin receptors. J Med Chem (2000) 1.05
Comparison of models describing the thermal lens effect. Appl Opt (1984) 1.04
Oxidative stress induced by glutamate receptor agonists. Brain Res (1993) 1.03
Effect of the prostaglandin synthetase inhibitor indomethacin on 7,12-dimethylbenz(a)anthracene-induced mammary tumorigenesis in rats fed different levels of fat. Cancer Res (1983) 1.02
Management of warm-season grass mixtures for biomass production in South Dakota USA. Bioresour Technol (2007) 1.02
An experimental strategy to dramatically reduce the RF power used in cross polarization solid-state NMR spectroscopy. J Am Chem Soc (2001) 1.02
Nonenzymatic glucosylation of serum proteins and hemoglobin: response to changes in blood glucose levels in diabetic rats. Diabetes (1980) 1.02
Celecoxib induces hepatic stellate cell apoptosis through inhibition of Akt activation and suppresses hepatic fibrosis in rats. Gut (2009) 1.01
Review of diclofenac and evaluation of its place in therapy as a nonsteroidal antiinflammatory agent. Drug Intell Clin Pharm (1988) 1.00
Cyclophilin A-induced alterations of human immunodeficiency virus type 1 CA protein in vitro. J Virol (1997) 0.99
Spectral analysis and tryptic susceptibility as probes of HIV-1 capsid protein structure. Virology (1994) 0.98
Requirement of essential fatty acid for mammary tumorigenesis in the rat. Cancer Res (1985) 0.97
Metastatic involvement of the stomach secondary to lung carcinoma. J Korean Med Sci (1993) 0.97
Familial central nervous system neoplasia. Case report of a family with von Recklinghausen's neurofibromatosis. Arch Neurol (1969) 0.96
TRH-R2 exhibits similar binding and acute signaling but distinct regulation and anatomic distribution compared with TRH-R1. Mol Endocrinol (2000) 0.95
Comparison of the beta-adrenoceptor affinity and selectivity of cetamolol, atenolol, betaxolol, and ICI-118,551. J Cardiovasc Pharmacol (1988) 0.94
Expression patterns of alpha-synuclein in human hematopoietic cells and in Drosophila at different developmental stages. Mol Cells (2000) 0.94
Innervation of the lower eyelid in relation to blepharoplasty and midface lift: clinical observation and cadaveric study. Ann Plast Surg (2001) 0.93
Inhibition of fos-jun-DNA complex formation by dihydroguaiaretic acid and in vitro cytotoxic effects on cancer cells. Cancer Lett (1998) 0.93
Contrasting splenic mechanisms in the blood clearance of red blood cells and colloidal particles. Blood (1975) 0.92
Endoscopic mucosal resection with a ligation device for early gastric cancer and precancerous lesions: comparison of its therapeutic efficacy with surgical resection. Yonsei Med J (2000) 0.92
Posttranscriptional regulation of human ADH5/FDH and Myf6 gene expression by upstream AUG codons. Arch Biochem Biophys (2001) 0.91
The effect of an aldose reductase inhibitor on the galactose-exposed rabbit lens. Biochim Biophys Acta (1968) 0.90
Evaluation of the effectiveness of two support surfaces following myocutaneous flap surgery. Adv Wound Care (1995) 0.90
Methylation of reovirus oligonucleotides in vivo and in vitro. Virology (1977) 0.90
Corneal cell culture and organ storage. Trans Ophthalmol Soc U K (1986) 0.90
A case of pancreatico-colo-cutaneous fistula; management guided by endoscopic retrograde cholangio-pancreatography. J Korean Med Sci (1989) 0.89
Ipsilateral ptosis associated with anterior thalamic infarction. Cerebrovasc Dis (2004) 0.88
Elevated rates of early discontinuation from pharmacotherapy trials in alcoholics and drug abusers. Alcohol Clin Exp Res (1996) 0.87
Characterization of antiallodynic actions of ALE-0540, a novel nerve growth factor receptor antagonist, in the rat. J Pharmacol Exp Ther (1999) 0.86
Adrenergic beta receptors and plasma free fatty acids. J Pharmacol Exp Ther (1966) 0.86
A consensus conference on complex biologics and low molecular weight heparins. Int Angiol (2010) 0.86
Serpiginous choroidopathy presenting as choroidal neovascularisation. Br J Ophthalmol (2003) 0.85
Toxicities of 166Holmium-chitosan in mice. Arzneimittelforschung (1998) 0.85
Suppression of inflammatory responses by surfactin, a selective inhibitor of platelet cytosolic phospholipase A2. Biochem Pharmacol (1998) 0.84
Porcine feasibility and safety study of a new paclitaxel-eluting biliary stent with a Pluronic-containing membrane. Endoscopy (2012) 0.84
Activation of the complete mouse metallothionein gene locus in the maternal deciduum. Mol Reprod Dev (1996) 0.84
Long-term outcome when major complications follow coronary artery bypass graft surgery. Recovery after complicated coronary artery bypass graft surgery. Chest (1996) 0.84
Performance of diabetic rat hearts: effects of anoxia and increased work. Am J Physiol (1980) 0.84
Cervical spine involvement in longstanding ankylosing spondylitis. Clin Exp Rheumatol (2005) 0.83
DNA bending by asymmetrically tethered cations: influence of tether flexibility. Chem Biol (2001) 0.83
In-vitro and in-vivo activities of DW-116, a new fluoroquinolone. J Antimicrob Chemother (1997) 0.83
PITANSEMA-MAS, a solid-state NMR method to measure heteronuclear dipolar couplings under MAS. Chem Phys Lett (2005) 0.83
Release of 7-alkylguanines from N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosourea-modified DNA by 3-methyladenine DNA glycosylase II. Cancer Res (1991) 0.83
Etodolac kinetics in the elderly. Clin Pharmacol Ther (1986) 0.82
Activation of prostate-specific antigen precursor (pro-PSA) by prostin, a novel human prostatic serine protease identified by degenerate PCR. Biochemistry (2001) 0.82
Formation and Reactivity of the Osmium(IV)-Cyanoimido Complex [Os(IV) (bpy)(Cl)3 (NCN)](-). Angew Chem Int Ed Engl (2001) 0.82
Inhibition of the conversion of 7-dehydrocholesterol to cholesterol by AY-9944. Biochem Biophys Res Commun (1964) 0.82
Determination of binding constant of transcription factor AP-1 and DNA. Application of inhibitors. Eur J Biochem (2001) 0.82
Characterization of endothelin-induced nociception in mice: evidence for a mechanistically distinct analgesic model. J Pharmacol Exp Ther (1996) 0.82
Experimental ulcerative herpetic keratitis. IV. Preliminary observations on the efficacy of a herpes simplex subunit vaccine. Br J Ophthalmol (1981) 0.82
Successful endoscopic management of a perforated gastric dysplastic lesion after endoscopic mucosal resection. Gastrointest Endosc (2000) 0.82
Tissue-dependent alpha adrenoceptor activity of buspirone and related compounds. J Pharmacol Exp Ther (1987) 0.82
Respiratory failure in the elderly. Analysis of outcome after treatment with mechanical ventilation. Arch Intern Med (1993) 0.82
A comparison of antihypertensive effects between two formulations of atenolol: tenolol and tenormin. Zhonghua Yi Xue Za Zhi (Taipei) (1995) 0.82
The metabolic disposition of etodolac in rats, dogs, and man. Drug Metab Rev (1981) 0.82
2-Chloroethyl-3-sarcosinamide-1-nitrosourea, a novel chloroethylnitrosourea analogue with enhanced antitumor activity against human glioma xenografts. Cancer Res (1997) 0.81
Botulinum a toxin treatment of hemifacial spasm and blepharospasm. J Korean Med Sci (1993) 0.81
Stimulation of CD4+ T lymphocytes by allogeneic MHC peptides presented on autologous antigen-presenting cells. Evidence of the indirect pathway of allorecognition in some strain combinations. Transplantation (1992) 0.81
Characterization of a recombinant antibody produced in the course of a high yield fed-batch process. Biotechnol Bioeng (1994) 0.81
Ileal vasculitis in Henoch-Schönlein purpura. Gastrointest Endosc (2001) 0.81
Sprouty 2 binds ESCRT-II factor Eap20 and facilitates HIV-1 gag release. J Virol (2011) 0.81
Ascorbic acid promotes recovery of cellular functions following toxicant-induced injury. Toxicol Appl Pharmacol (2000) 0.81
Pneumosinus dilatans multiplex, mental retardation, and facial deformity. J Craniofac Surg (2000) 0.81